Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2008;94:131-132; doi:10.1136/hrt.2007.115188
Copyright © 2008 BMJ Publishing Group Ltd & British Cardiovascular Society

EDITORIALS

Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?

Philippe Meurin, Jean Yves Tabet

Les Grands Prés, Villeneuve Saint Denis, France

Correspondence to:
Dr P Meurin, Les Grands Prés, 27 rue Sainte Christine, 77174 Villeneuve Saint Denis, France; philippemeurin@hotmail.com

The first 150 words of the full text of this article appear below.

The risk of thromboembolism is high during the first month after mechanical prosthetic heart valve (MPHV) surgery,1 2 particularly during the lag time before oral anticoagulant (OAC) treatment reaches effective levels. Indeed, vitamin K antagonists (VKAs) take at least 5 days theoretically—and about 2 weeks in practice3—to achieve a therapeutic international normalised ratio.

A "bridging" anticoagulant is usually prescribed to cover this period. Traditionally, the bridging agent has been unfractionated heparin (UH),4 but low molecular weight heparin (LMWH) has been used more recently.3 5 6 As there are few studies to validate the efficacy and safety of either UH or LMWH in this setting, the need for heparin remains controversial and practice guidelines are not very clear cut.1 Thus, in some centres, OAC starts with VKA monotreatment, so that bridging does not become necessary unless there is an unusual delay in achieving a therapeutic international normalised ratio.4 7 8 However, a recent survey4 confirms . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Enoxaparin as bridging anticoagulant treatment in cardiac surgery
N Rivas-Gándara, I Ferreira-González, P Tornos, A Torrents, G Permanyer-Miralda, I Nicolau, E Arellano-Rodrigo, N Vallejo, A Igual, and J Soler-Soler
Heart 2008 94: 205-210. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.